Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001638599-19-001011

EVP and Chief Financial Office sold 17,250 shares at $0.41 ($7,076)

  • EVP and Chief Financial Office acquired 57,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
BROWN MORGAN R EVP and Chief Financial Office 2019-12-04 Option exercise +57,500 81,062 D
BROWN MORGAN R EVP and Chief Financial Office 2019-12-04 Sale −17,250 $0.41 $7,076 63,812 D
Derivatives
BROWN MORGAN R EVP and Chief Financial Office 2019-12-04 Option exercise · Restricted Stock Unit −57,500 57,500 D
BROWN MORGAN R EVP and Chief Financial Office 2019-12-05 Grant or award · Restricted Stock Unit +70,754 70,754 D
Open-market sales · 17,250 sh · avg $0.41 · $7,076
Loading xslF345X03/doc4_6380.xml…